|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(3R)-3-{[6-(4-methylphenyl)pyridin-3-yl]oxy}-1-azabicyclo[2.2.2]octane |
Database Links ![]() |
|
CAS Registry No. | 669770-29-0 (source: Scifinder) |
GtoPdb PubChem SID | 178103943 |
PubChem CID | 50914822 |
Search Google for chemical match using the InChIKey | NPDLTEZXGWRMLQ-IBGZPJMESA-N |
Search Google for chemicals with the same backbone | NPDLTEZXGWRMLQ |
Search UniChem for chemical match using the InChIKey | NPDLTEZXGWRMLQ-IBGZPJMESA-N |
Search UniChem for chemicals with the same backbone | NPDLTEZXGWRMLQ |
Comments |
AQW 051 is an α7 nicotinic acetylcholine receptor (nAChR) agonist from Novartis for the oral treatment of cognitive deficits in schizophrenia, Alzheimer's, and Parkinson's diseases. Structure first disclosed at March 2014 ACS meeting. The (3S) version is CID 71553840 |